Cardiovascular molecular imaging.
The goal of this review is to highlight how molecular imaging will impact the management and improved understanding of the major cardiovascular diseases that have substantial clinical impact and research interest. These topics include atherosclerosis, myocardial ischemia, myocardial viability, heart failure, gene therapy, and stem cell transplantation. Traditional methods of evaluation for these diseases will be presented first, followed by methods that incorporate conventional and molecular imaging approaches.
Wu
Joseph C
JC
Department of Medicine, Division of Cardiology, Department of Radiology, Molecular Imaging Program at Stanford, and Bio-X Program, Stanford University, 300 Pasteur Dr, Edwards Bldg R354, Stanford, CA 94305-5344, USA. joewu@stanford.edu
Bengel
Frank M
FM
Gambhir
Sanjiv S
SS
D000818:Animals; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000628:therapy*; D003287:Contrast Media / Q000494:pharmacology; D003952:Diagnostic Imaging / Q000379:methods*; D015316:Genetic Therapy; D006801:Humans; D015336:Molecular Probe Techniques; D015335:Molecular Probes; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals / Q000494:pharmacology; D033581:Stem Cell Transplantation
D003287:Contrast Media; D015335:Molecular Probes; D019275:Radiopharmaceuticals